Loading provider…
Loading provider…
Hematology & Oncology Physician in Hattiesburg, MS
NPI: 1134238496Primary Practice Location
FORREST GENERAL HOSPITAL
6051 US 49, Hattiesburg, MS
Primary Employer
Hattiesburg Clinic PA
hattiesburgclinic.com
HQ Phone
Get MD John's Phone Numberphone_androidMobile
Get MD John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 760 | 2,112 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 751 | 2,480 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 460 | 563 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 290 | 1,039 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 153 | 1,138 |
Authors: Alberto Bessudo, Stephen Lim, Jacob Bitran, Shahrooz Eshaghian, James Berenson, Mehdi Moezi
Journal: Exp Hematol
Publication Date: 2022-04-10
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.
Authors: Chainarong Limvarapuss, Naiyer Rizvi
Publication Date: 2018-03-16
Oxaliplatin as a radiosensitizing agent in rectal cancer.
Authors: Sergio Huerta
Journal: Anticancer Drugs
Lead Sponsor: Sermonix Pharmaceuticals Inc.
Collaborators: Linical Accelovance Group
Intervention / Treatment: DRUG: Fulvestrant, DRUG: Lasofoxifene
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
Lead Sponsor: BeyondSpring Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Docetaxel + Plinabulin (DP), DRUG: Docetaxel (D)